Joseph Daval (@DavalJoseph) profile picture

Postdoc fellow @PORTAL_Research. @YaleLawSch '21; @ASU '18.

Joined October 2016
Photo by Joseph Daval (@DavalJoseph)Photo by Joseph Daval (@DavalJoseph)Photo by Joseph Daval (@DavalJoseph)Photo by Joseph Daval (@DavalJoseph)Photo by Joseph Daval (@DavalJoseph)
Big Pharma's legal arguments against price negotiation are absurd. Pharmaceutical manufacturers are not entitled to limitless profits at the expense of the American taxpayer. They should not abuse the legal system to stop the IRA's drug price provisions from going into effect.
My op-ed today in @washingtonpost with @akesselheim on the Medicare drug lawsuits: washingtonpost.com/opinions/… Their arguments rely on the untenable premise that for-profit companies have a constitutionally protected right to receive taxpayer dollars.
3
6
24
7,387
Joseph Daval retweeted
Nice piece @DavalJoseph on protecting @CMSGov's coverage discretion: "A system in which taxpayers are required to pay for inferior treatments is not a competitive marketplace—it is an entitlement program for for-profit companies subsidized by the public" jamanetwork.com/journals/jam…
1
3
11
1,011
Joseph Daval retweeted
🔥 🔥 🔥 @JAMA_current viewpoint by @DavalJoseph @LiamBendicksen @akesselheim. Protecting Medicare’s Discretion to Say No to Unproven Therapies jamanetwork.com/journals/jam… – at Wellesley, MA
1
7
1
17
3,750
We had our annual @PORTAL_Research retreat yesterday! Always inspired by this group. Looking forward to the year ahead in pharmaceutical policy!
1
3
2
20
3,588
Consistent alignment with advisory recommendations, along with an overall decrease in meetings, suggests that FDA is leaning away from independent expert advice even as it continues to follow it, according to this quality improvement study. ja.ma/3NGcsmr @akesselheim
3
1
5
1,482
Joseph Daval retweeted
The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm. nej.md/3J8jKx0
6
10
1
30
28,678
New @PORTAL_Research perspective out @NEJM this week from @DavalJoseph @LiamBendicksen @akesselheim
The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm. nej.md/3J8jKx0
2
4
784
Should FDA be an independent agency? In particular, should it be able to litigate independently w/o DOJ’s involvement? @DavalJoseph: it’s complicated! DOJ limits FDA choices; distinct priorities; sometimes *more* enforcement. papers.ssrn.com/sol3/papers.… #HLP22 @PORTAL_Research
2
5
18
Joseph Daval retweeted
Presenting new work this afternoon @ASLMENews #HLP22 I'm on a panel with @WNicholsonPrice @UMichLaw, @gerke_sara @DickinsonLaw & @DavalJoseph @PORTAL_Research. Join us as we take a deep dive into the nuances of FDA law and policy!
3
11
1
20
At #HLP22 @ASLMENews, PORTAL fellow @DavalJoseph presents "Independence & Influence in FDA Decisionmaking"
1
10
1
18
In their new Health Affairs paper,@DavalJoseph of @BrighamWomens & @Harvard and coauthors examine the 482 new drugs and biologics approved by the @US_FDA between 2010-21, with a particular focus on the 10 drugs approved despite a negative advisory committee vote. #Pharmaceuitcals

4
2
In his new blog, @DavalJoseph from @PORTAL_Research argues that by rescinding Trump’s #PublicCharge Rule, the Biden administration must now decide how it will interpret the same underlying law, which excludes immigrants likely to become a “public charge.” https://nitter.gq/t.co/PJ95X8Hj0y
And you can read @DavalJoseph’s student category piece, “The Problem with Public Charge”, at https://nitter.gq/t.co/g07IQzehya Congrats, Joseph!
1
3